Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1145991517 | 11459915 | 17 | F | 2014 | 20160926 | 20150904 | 20160929 | EXP | PHHY2015IQ103312 | NOVARTIS | 27.31 | YR | F | Y | 0.00000 | 20160929 | MD | IQ | IQ |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1145991517 | 11459915 | 1 | SS | GLIVEC | IMATINIB MESYLATE | 1 | Unknown | U | 0 | ||||||||||
| 1145991517 | 11459915 | 2 | PS | TASIGNA | NILOTINIB | 1 | Oral | 800 MG, QD | 22068 | 800 | MG | CAPSULE | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 1145991517 | 11459915 | 1 | Product used for unknown indication |
| 1145991517 | 11459915 | 2 | Chronic myeloid leukaemia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 1145991517 | 11459915 | Abdominal pain | |
| 1145991517 | 11459915 | Arthralgia | |
| 1145991517 | 11459915 | Bladder pain | |
| 1145991517 | 11459915 | Bone pain | |
| 1145991517 | 11459915 | Boredom | |
| 1145991517 | 11459915 | Chromaturia | |
| 1145991517 | 11459915 | Decreased appetite | |
| 1145991517 | 11459915 | Diarrhoea | |
| 1145991517 | 11459915 | Dry skin | |
| 1145991517 | 11459915 | Dyspnoea | |
| 1145991517 | 11459915 | Ear pain | |
| 1145991517 | 11459915 | Fatigue | |
| 1145991517 | 11459915 | Haemoptysis | |
| 1145991517 | 11459915 | Headache | |
| 1145991517 | 11459915 | Hepatic enzyme increased | |
| 1145991517 | 11459915 | Influenza | |
| 1145991517 | 11459915 | Malaise | |
| 1145991517 | 11459915 | Menstrual disorder | |
| 1145991517 | 11459915 | Oropharyngeal pain | |
| 1145991517 | 11459915 | Pain | |
| 1145991517 | 11459915 | Pain in extremity | |
| 1145991517 | 11459915 | Polymerase chain reaction positive | |
| 1145991517 | 11459915 | Pyrexia | |
| 1145991517 | 11459915 | Renal pain | |
| 1145991517 | 11459915 | Skin discolouration | |
| 1145991517 | 11459915 | Skin exfoliation | |
| 1145991517 | 11459915 | Spinal pain | |
| 1145991517 | 11459915 | Tachycardia | |
| 1145991517 | 11459915 | Tonsillar disorder | |
| 1145991517 | 11459915 | Tooth disorder | |
| 1145991517 | 11459915 | Urinary tract infection | |
| 1145991517 | 11459915 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 1145991517 | 11459915 | 2 | 201406 | 0 |